Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CXADR |
| Upstream (Parents) |
|---|
| (<<) CCNE2 → CXADR |
| (<<) FGL2 → CXADR |
| (<<) BTG3 → CXADR |
| (<<) TPD52 → CXADR |
| (<<) HCLS1 → CXADR |
| Downstream (Children) |
|---|
| CXADR → ETS2 (>>) |
| CXADR → ZBTB10 (>>) |
| CXADR → HOXB13 (>>) |
| CXADR → CD28 (>>) |
| CXADR → SIGLEC8 (>>) |
| CXADR → PVT1 (>>) |
| CXADR → TAF4 (>>) |
| CXADR → NIN (>>) |
| CXADR → PDE5A (>>) |
| CXADR → PSG5 (>>) |
| CXADR → RICH2 (>>) |
| CXADR → HIST1H3H (>>) |
| CXADR → PLEKHF1 (>>) |
| CXADR → BTG3 (>>) |
| CXADR → MLLT4 (>>) |
| CXADR → BEX4 (>>) |
| CXADR → SLC5A3 (>>) |
| CXADR → NEDD4L (>>) |
| CXADR → SYTL2 (>>) |
